Showing results (161-170 of 171) with videos related to
Sort By:
Pageof 18
Oncotarget|July 23, 2016
CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patientYu-Chia Chen, Hao-Yi Li, Jui-Lin Liang, et al.Forest Ecology and Management|March 27, 2023
The complexity of biological disturbance agents, fuels heterogeneity, and fire in coniferous forests of the western United StatesDavid C Shaw, Peter A Beedlow, E Henry Lee, et al.Iscience|April 3, 2023
The importance of unambiguous cell origin determination in neuronal repopulation studiesThomas V Johnson, David J Calkins, Brad Fortune, et al.BMC Neurology|July 12, 2022
Absence of lenadogene nolparvovec DNA in a brain tumor biopsy from a patient in the REVERSE clinical study, a case reportNancy J Newman, Matthew Schniederjan, Pia R Mendoza, et al.Breast Cancer Research : BCR|December 21, 2017
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancerHao-Yi Li, Jui-Lin Liang, Yao-Lung Kuo, et al.American Journal of Respiratory and Critical Care Medicine|November 24, 2015
Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal TransitionChe-Yu Hsu, Cheng-Han Lin, Yi-Hua Jan, et al.Therapeutic Advances in Medical Oncology|October 22, 2019
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinomaCheng-Han Lin, Hao-Yi Li, Yu-Peng Liu, et al.Scientific Reports|January 17, 2018
Modulation of UVB-induced Carcinogenesis by Activation of Alternative DNA Repair PathwaysYan Sha, Vladimir Vartanian, Nichole Owen, et al.Oncotarget|May 21, 2016
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinomaCheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, et al.Molecular Neurodegeneration|March 22, 2022
Solving neurodegeneration: common mechanisms and strategies for new treatmentsLauren K Wareham, Shane A Liddelow, Sally Temple, et al.Pageof 18